Aptevo Therapeutics Inc. Class of Warrant or Right, Outstanding
Aptevo Therapeutics Inc. (APVO) had Class of Warrant or Right, Outstanding of 730.17 thousand shares as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2026-08-14
- 2026-06-30: Class of Warrant or Right, Outstanding 730.17K shares.
- 2025-12-31: Class of Warrant or Right, Outstanding 676.97K shares; Class of Warrant or Right, Outstanding as first filed 1.67M shares.
- 2025-09-30: Class of Warrant or Right, Outstanding 12.54M shares.
- 2025-06-30: Class of Warrant or Right, Outstanding 12.59M shares.
| Period end | Class of Warrant or Right, Outstanding | Class of Warrant or Right, Outstanding as first filed |
|---|---|---|
| 2026-06-30 | 730.17K shares 10-Q · filed 2026-08-14 | |
| 2025-12-31 | 676.97K shares 10-Q · filed 2026-08-14 | 1.67M shares 10-Q · filed 2025-05-15 |
| 2025-09-30 | 12.54M shares 10-Q · filed 2025-11-06 | |
| 2025-06-30 | 12.59M shares 10-Q · filed 2025-08-11 | |
| 2024-12-31 | 4.65K shares 10-K · filed 2026-03-26 | 1.67M shares 10-K · filed 2025-02-14 |
| 2024-09-30 | 36.35M shares 10-Q · filed 2024-11-07 | |
| 2024-06-30 | 7.49M shares 10-Q · filed 2024-08-08 | |
| 2023-12-31 | 18.86K shares 10-K · filed 2025-02-14 | 30.68M shares 10-K · filed 2024-03-05 |
| 2022-12-31 | 350.59K shares 10-K · filed 2024-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |